{
    "2021-05-07": [
        [
            {
                "time": "2021-05-07",
                "original_text": "The Tussle Over Covid Vaccine Patents Looks Overblown. Why Moderna and BioNTech Can Weather the Jolts.",
                "features": {
                    "keywords": [
                        "vaccine patents",
                        "Moderna",
                        "BioNTech"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-17",
                "original_text": "Pfizer Lifts Covid-19 Vaccine Production Targets for 2021, 2022",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "vaccine production",
                        "targets"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-20",
                "original_text": "AstraZeneca Weighs Seeking Full U.S. Approval for Covid Shot, Skipping Emergency-Use Application",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "U.S. approval",
                        "Covid shot"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-05",
                "original_text": "Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines",
                "features": {
                    "keywords": [
                        "Biotech ETFs",
                        "IP waiver",
                        "COVID-19 vaccines"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-06",
                "original_text": "Vaccine Stocks Take Wild Ride Amid Political Clash, Earnings",
                "features": {
                    "keywords": [
                        "vaccine stocks",
                        "political clash",
                        "earnings"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2021-05-07",
                "original_text": "Pfizer, BioNTech Seek Full FDA Approval For Covid Vaccine; Shares Pop",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "FDA approval",
                        "shares pop"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "Moderna and Pfizer vaccines show defense against variants",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Pfizer",
                        "variants"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}